Rising drug overdose deaths in chronic liver disease in the United States, 2015–2023
Open Access
- 1 July 2025
- journal article
- Published by The Korean Association for the Study of the Liver in Clinical and Molecular Hepatology
- Vol. 31 (3) , e277-e280
Abstract
Rising drug overdose deaths in chronic liver disease in the United States, 2015–2023Keywords
This publication has 13 references indexed in Scilit:
- Contemporary burden of mortality from chronic liver disease by sex and race/ethnicity in the United StatesClinical and Molecular Hepatology, 2025
- Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018–2023Clinical and Molecular Hepatology, 2024
- Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkageJournal of Substance Use and Addiction Treatment, 2024
- Overdose deaths before and during the COVID-19 pandemic in a US countyFrontiers in Public Health, 2024
- Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United StatesClinical Gastroenterology and Hepatology, 2022
- Trends in mortality in hepatitis C infection and alcoholic liver disease based on drug overdose in the United StatesJournal of Viral Hepatitis, 2020
- The changing opioid crisis: development, challenges and opportunitiesMolecular Psychiatry, 2020
- The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisisInternational Journal of Drug Policy, 2019
- Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016Gastroenterology, 2018
- Direct-acting antiviral agents for HCV infection affecting people who inject drugsNature Reviews Gastroenterology & Hepatology, 2017